**Contents**


Reprinted from: *Antibiotics* **2021**, *10*, 219, doi:10.3390/antibiotics10020219 . . . . . . . . . . . . . . **113**

#### **Tomokazu Shoji, Natsu Sato, Haruhisa Fukuda, Yuichi Muraki, Keishi Kawata and Manabu Akazawa**

Clinical Implication of the Relationship between Antimicrobial Resistance and Infection Control Activities in Japanese Hospitals: A Principal Component Analysis-Based Cluster Analysis Reprinted from: *Antibiotics* **2022**, *11*, 229, doi:10.3390/antibiotics11020229 . . . . . . . . . . . . . . **121**

#### **Bing-Mu Hsu, Jung-Sheng Chen, I-Ching Lin, Gwo-Jong Hsu, Suprokash Koner and Bashir Hussain et al.**


#### **Dawid Rozenkiewicz, Erika Esteve-Palau, Mar Arenas-Miras, Santiago Grau, Xavier Duran and Luisa Sorl´ı et al.**

Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing *Klebsiella pneumoniae* Requiring Hospitalization in Spain: An Observational Cohort Study

Reprinted from: *Antibiotics* **2021**, *10*, 585, doi:10.3390/antibiotics10050585 . . . . . . . . . . . . . . **149**

#### **R ˘azvan-Cosmin Petca, Silvius Negoit, ˘a, Cristian Mares, , Aida Petca, R˘azvan-Ionut, Popescu and C ˘alin Bogdan Chibelean**

Heterogeneity of Antibiotics Multidrug-Resistance Profile of Uropathogens in Romanian Population

Reprinted from: *Antibiotics* **2021**, *10*, 523, doi:10.3390/antibiotics10050523 . . . . . . . . . . . . . . **159**

#### **Wasan Katip, Suriyon Uitrakul and Peninnah Oberdorfer**

Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant *A. baumannii* in Cancer Patient

Reprinted from: *Antibiotics* **2021**, *10*, 484, doi:10.3390/antibiotics10050484 . . . . . . . . . . . . . . **173**

#### **Alessandra Oliva, Alessandro Bianchi, Alessandro Russo, Giancarlo Ceccarelli, Francesca Cancelli and Fulvio Aloj et al.**

Effect of *N*-Acetylcysteine Administration on 30-Day Mortality in Critically Ill Patients with Septic Shock Caused by Carbapenem-Resistant *Klebsiella pneumoniae* and *Acinetobacter baumannii*: A Retrospective Case-Control Study

Reprinted from: *Antibiotics* **2021**, *10*, 271, doi:10.3390/antibiotics10030271 . . . . . . . . . . . . . . **185**
